• #1154800
  • 151
  • Glaxo Smith Kline #58160088552

Fluarix® Quadrivalent 2020 - 2021 Flu Vaccine 60 mcg / 0.5 mL Indicated For People 6 Months of Age and Above Prefilled Syringe 0.5 mL

FLUARIX QUAD 2020, SYR 0.5ML (10DOSE/BX)

Features
  • Fluarix is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
  • Fluarix is approved for use in persons 6 months of age and older
  • Each 0.5 mL dose is supplied in single-dose prefilled TIP-LOK® syringes
  • More …
  Log In to Order
or

Professionals Also Viewed


Product Specifications


McKesson #1154800
Manufacturer #58160088552
BrandFluarix® Quadrivalent 2020 - 2021
ManufacturerGlaxo Smith Kline
Country of OriginUnknown
ApplicationFlu Vaccine
Container TypePrefilled Syringe
Dosage FormInjection
NDC Number58160-0885-52
Product DatingMcKesson Acceptable Dating: we will ship >= 90 days
Storage RequirementsRequires Refrigeration
Strength60 mcg / 0.5 mL
TypeIntramuscular
UNSPSC Code51201608
UserIndicated For People 6 Months of Age and Above
Volume0.5 mL
Features
  • Fluarix is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
  • Fluarix is approved for use in persons 6 months of age and older
  • Each 0.5 mL dose is supplied in single-dose prefilled TIP-LOK® syringes
  • FLUARIX QUADRIVALENT has been standardized according to U.S. Public Health Service (USPHS) requirements for the 2020 - 2021 influenza season and is formulated to contain 60 micrograms (mcg) hemagglutinin (HA) per 0.5-mL dose, in the recommended ratio of 15 mcg HA of each of the following 4 influenza virus strains (2 A strains and 2 B strains): A/Brisbane/02/2018 (H1N1) pdm09 (IVR-190), A/Kansas/14/2017 (H3N2) NYMC X-327, B/Maryland/15/2016 NYMC BX-69A (a B/Colorado/06/2017-like virus), and B/Phuket/3073/2013.